Current position:Home >Product >
4-chloro-2-nitro-6-[2,2,2-trichloro-1-(5-chloro-2-hydroxy-3-nitro-phenyl)ethyl]phenol
4-chloro-2-nitro-6-[2,2,2-trichloro-1-(5-chloro-2-hydroxy-3-nitro-phenyl)ethyl]phenol(7511-33-3)
- Name: 4-chloro-2-nitro-6-[2,2,2-trichloro-1-(5-chloro-2-hydroxy-3-nitro-phenyl)ethyl]phenol
- Synonyms:
- Molecular Formula:C14H7Cl5N2O6
- Molecular Weight:476.4802
- CAS Registry Number:7511-33-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.7511-33-3 4-chloro-2-nitro-6-[2,2,2-trichloro-1-(5-chloro-2-hydroxy-3-nitro-phenyl)ethyl]phenol
Assay:90%,98% Appearance:detailed see specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by air or by sea Application:Used in Synthesis, Pharmaceuticals and other fields
Min. Order:1Kilogram
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)] CAS No.7511-33-3 7511-33-3
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)]
Other Product
- 56469-15-9/cis-(±)-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one
- 73607-59-7/(4R)-15β-Acetoxy-7β-[[(Z)-2-methyl-1-oxo-2-butenyl]oxy]kaur-16-en-18-oic acid
- 59068-49-4/Neomycin,sulfate (salt),mixt. with (4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-1,4,- 4a,5,5a,6,11,12a-octahydro-3,6,10,12,12apentahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide monohydrochloride and 3-[[(5-nitro-2-furanyl)methylene]amino]-2- oxazolidinone
- 90170-73-3/9,10-Anthracenedione, 1,5(or 1,8)-diamino-4,8(or 4,5)-dihydroxy-, reaction products with 2-chlorobenzothiazole
- 1840-42-2/Fluorotrinitromethane
- 143810-44-0/7H-Thieno[3,2-g][1]benzothiopyran-7-one
- 70768-44-4/enkephalin, Cys(2)-CysNH2(5)-
- 134956-10-8/Pestalopyrone
- 15644-80-1/2,8-DIMETHYL-4-HYDROXYQUINOLINE
- 65651-05-0/Ircodin
- 15515-40-9/Ethanamine,2,2'-[(1,2-dimethyl-1,2-ethanediyl)bis(4,1-phenyleneoxy)]bis[N,N-diethyl-,dihydrochloride, [R-(R*,S*)]- (9CI)
- 16180-96-4/2-acetamidoethyl acetate
- 70145-85-6/[2-(3-methoxyphenoxy)ethyl]diazanium (2Z)-3-carboxyprop-2-enoate
- 53152-57-1/Cardanolide, 3-((O-2,6-dideoxy-4-O-methyl-beta-D-ribo-hexopyranosyl-(1.4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1.4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-
- 92999-26-3/5,12-Naphthacenedione, 7,8,9,10-tetrahydro-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-6,9,11-trihydroxy-9-(1-hydroxyethyl)-, hydrochloride, (7S-(7-alpha,9-alpha,9(S*)))-
- 1514-16-5/1-fluoro-9H-fluoren-9-one
- 94790-30-4/L-N-((2-Chloroethyl)nitrosocarbamoyl)valine methyl ester
- 7230-91-3/1-methyl-3-{[(1,5,7-trimethyl-2,4-dioxo-3-azabicyclo[3.3.1]non-7-yl)carbonyl]amino}quinolinium
- 116990-01-3/6H-Indolo[2,3-b]quinoxaline-6-aceticacid, 9-chloro-, 2-(1-phenylethylidene)hydrazide
- 7511-33-3/4-chloro-2-nitro-6-[2,2,2-trichloro-1-(5-chloro-2-hydroxy-3-nitro-phenyl)ethyl]phenol
- 182261-94-5/Clausine I
- 125791-43-7/3-hydroxy-1-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)butan-1-one
- 192863-87-9/Isodoglutinosin B
- 5669-69-2/(5E)-5-{[5-(2,4-dichlorophenyl)furan-2-yl]methylidene}-3-ethyl-2-thioxo-1,3-thiazolidin-4-one
- 13935-00-7/1-NAPHTHOL-3-SULFONIC ACID SODIUM SALT
- 31983-33-2/(9E,12S)-12-hydroxyoctadec-9-enoic acid
- 2686-05-7/(3aS,5aS,13aR,13bS)-9-methoxy-3a-methyl-1,2,3a,4,5,5a,12,13,13a,13b-decahydro-3H-6,11-methanocyclodeca[e]inden-3-one
- 60055-30-3/2-hydroxy-1-nitro-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one
- 68070-93-9/2-Propanol, 1,1-oxybis-, ester with boric acid (H3BO3)
- 27506-83-8/5,5-diethyl-1,3-bis(methoxymethyl)pyrimidine-2,4,6(1H,3H,5H)-trione